322. Hemophilia A and B: Clinical and Epidemiological: Poster I
0 activities
A Fixed (Weight-independent) Subcutaneous Once-Weekly Dose for Marstacimab, an Anti-TFPI Monoclonal Antibody for the Prophylactic Treatment of Hemophilia Α and B
1 activities
A Fixed (Weight-independent) Subcutaneous Once-Weekly Dose for Marstacimab, an Anti-TFPI Monoclonal Antibody for the Prophylactic Treatment of Hemophilia Α and B
A Specific Coagulation Factor X Activator for on-Demand Treatment in Hemophilia with Inhibitors
1 activities
A Specific Coagulation Factor X Activator for on-Demand Treatment in Hemophilia with Inhibitors
ATHN Transcends Hemophilia Natural History Arm: Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia A and B
1 activities
ATHN Transcends Hemophilia Natural History Arm: Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia A and B
Bleed Patterns in Infants, from Birth to 12 Months of Age, with Hemophilia A Treated with Emicizumab: Exploratory Analysis of the HAVEN 7 Study
1 activities
Bleed Patterns in Infants, from Birth to 12 Months of Age, with Hemophilia A Treated with Emicizumab: Exploratory Analysis of the HAVEN 7 Study
Immune Toleration Induction with Emicizumab in Hemophilia a Patients with Inhibitors: A Systematic Review
1 activities
Immune Toleration Induction with Emicizumab in Hemophilia a Patients with Inhibitors: A Systematic Review
Impact of Emicizumab on Mental Liberation in Adult Patients with Severe and Moderate Factor VIII Deficiency
1 activities
Impact of Emicizumab on Mental Liberation in Adult Patients with Severe and Moderate Factor VIII Deficiency
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-Reported Outcomes for Hemophilia A in the FRONTIER2 Study
1 activities
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-Reported Outcomes for Hemophilia A in the FRONTIER2 Study
Retrospective Study of Intraarticular Synovectomy in Chronic Synovitis in Person with Hemophilia
1 activities
Retrospective Study of Intraarticular Synovectomy in Chronic Synovitis in Person with Hemophilia
Safety Biomarkers in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B Without Inhibitors Receiving Prophylactic Marstacimab Treatment: Results From the Phase 3 BASIS Trial
1 activities
Safety Biomarkers in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B Without Inhibitors Receiving Prophylactic Marstacimab Treatment: Results From the Phase 3 BASIS Trial
TSUBASA Study: A Prospective Study Evaluating the Association between Physical Activity and Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors
1 activities
TSUBASA Study: A Prospective Study Evaluating the Association between Physical Activity and Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors
The Influence of Postpartum Hemorrhage on the Quality of Life Among Pregnant Hemophilia a and B Carriers: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)
1 activities
The Influence of Postpartum Hemorrhage on the Quality of Life Among Pregnant Hemophilia a and B Carriers: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)
Trends in Outcomes and Hospitalisation of Head and Neck of Femur Fractures in Patients with Hemophilia - an Analysis of the National Inpatient Sample (NIS) (2016-2020)
1 activities
Trends in Outcomes and Hospitalisation of Head and Neck of Femur Fractures in Patients with Hemophilia - an Analysis of the National Inpatient Sample (NIS) (2016-2020)